Reuters: Regulatory News: UPDATE 1-Medtox Scientific's 1st-qtr beats expectations

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-Medtox Scientific's 1st-qtr beats expectations Apr 12th 2012, 14:38 Thu Apr 12, 2012 10:38am EDT April 12 (Reuters) - Medtox Scientific Inc posted quarterly results that beat market expectations, helped by strong revenue in its clinical laboratory segment, sending its shares up to a year high. For the first quarter, Medtox's net income rose to $1.5 million, or 17 cents a share, from $0.8 million, or 9 cents a share, a year ago. Revenue was up 14 percent at $28.6 million. Clinical laboratory revenue jumped 25 percent to $9.2 million. Analysts expected earnings of 13 cents a share on revenue of $27.5 million, according to Thomson Reuters I/B/E/S. The company's shares were trading up 7 percent at $19.10 on Thursday on the Nasdaq. They had touched a high of $19.81 earlier in the session.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions